Skip to content
OGN Organon & Co. NYSE
19.54 USD -1.61% -0.32
OPEN 19.91
DAY RANGE 20.09 - 19.43
52 WEEK RANGE 39.09 - 19.15
Interactive Brokers Logotype

Buy OGN stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 5.2B
Enterprise value 13.5B
Trailing pe 7.09375
Forward pe 4.4704595
Peg ratio 4.4704595
Price to sales ttm 0.847993
Price to book mrq 7.8240563149606
Enterprise to revenue 2.197
Enterprise to ebitda 7.555


Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin 0.121400006
Operating margin 0.25566
Return on assets ttm 0.09194
Return on equity ttm -1.0280269058296
Income statement
Revenue ttm 6.1B
Revenue per share ttm 24.166
Quarterly revenue growth -0.019
Gross profit ttm 3.9B
Ebitda 1.6B
Net income to common ttm 746M
Diluted eps ttm 2.88
Quarterly earnings growth yoy -0.491
Balance sheet
Total cash mrq 459M
Total cash per share mrq 1.8
Total debt mrq 8.7B
Total debt to equity mrq -11.819538757123
Current ratio mrq 1.611
Book value per share mrq -2.897
Cash flow
Operating cash flow ttm 849M
Levered free cash flow ttm 321.2M

Stock statistics

Shares outstanding 255.1M
Float shares 254.7M
Avg 10 volume 2.4M
Avg 30 volume 1.8M
Shares short 6.2M
Short ratio 4.18
Short percent of shares outstanding 0.0277
Percent held by insiders 0.00081
Percent held by institutions 0.80054003

Stock price summary

Fifty two week low 20.12
Fifty two week high 39.09
Fifty two week change -94.268
Beta 0.724265
Day 50 ma 22.6948
Day 200 ma 26.2068

Dividends and splits

Forward annual dividend rate 1.12
Forward annual dividend yield 0.0544
Trailing annual dividend rate 1.12
Trailing annual dividend yield 0.054714218
Payout ratio 0.3836
Dividend date 2023-06-15
Ex dividend date 2023-05-12

Organon & Co ( OGN) company profile

Organon & Co. (NYSE: OGN) is a science-based pharmaceutical company that develops and delivers health solutions. The company’s portfolio entails prescription therapies within women’s health, biosimilars. It operates through the segments of Organon Products and Products, which entails Women’s Health, Biosimilars, and Established Brands.